Healthcare Social Media and Updates
Healthcare Social Media and Updates
Healthcare Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Tech equity means every clinician, every patient, every setting. See how MEDITECH is bringing AI + interoperability to rural & urban care at #HIMSS26 👉 https://t.co/fz78ijGID8 📍 Booth #5031 @MEDITECH #HIMSS26 #HITSM
Lilly targets employers in new bid to broaden access to obesity drugs https://t.co/Y6fmcmTcf1 @ByJonGardner $LLY $NVO #obesity
China competition is coming for the US's multimillion-dollar gene therapies -- a must-read from @Jared_Whitlock about what's happening there and how it will affect access around the world: https://t.co/F7KaMv3Kkp
Agentic AI will automate tasks today — and redesign care models tomorrow. Hospitals & plans can’t afford to ignore this shift. Read the article 🔗 https://t.co/iAzZysMNQp And continue the conversation with NTT DATA at #HIMSS26 🙌 @NTT_DATA_NA #AgenticAI #HITSM
Can an AI model be a generalist to work and perform well for all types of medical images? Just published, our MedVersa paper @NEJM_AI Led by @pranavrajpurkar Free access https://t.co/5llNf94hAF https://t.co/Bf01zUZ1sk
20 years of Yamanaka stem cell factor research culminates in 2 conditional approvals for heart disease and Parkinson's disease in Japan https://t.co/8oxKxXYafu by Shinya Yamanaka @CellStemCell https://t.co/U878IxSfSi @ScienceMagazine https://t.co/HCCPaTEP7e
Erythrocyte–anti-PD1 conjugates in persons with advanced solid tumors resistant to anti-PD1/PDL1: preclinical characterization and results of a phase 1 trial https://t.co/1GQMlUHn4Y https://t.co/0it5nTvUm0
Amazing quote in this NYT story on the FDA from @By_CJewett. Janet Woodcock, a top drug regulator for decades, said reversals for a promising therapy send shock waves through the industry. “The Huntington’s refusal I thought was truly evil,” she told NYT....
My friend @adamfeuerstein delivers some great reporting and smart commentary on the FDA's direction that $QURE conduct a new randomized trial for its Huntington's drug. A senior FDA official and the company disagree on the basic question of whether the...
In this week's Biotech Scorecard newsletter: The extremism of the FDA’s Peter Marks and Vinay Prasad has come with costs Two regulators, two extreme regulatory philosophies, one replacing the other. The rare disease community is suffering whiplash. Drugmakers ( $QURE...
The hardest conversation I have in my office isn't about surgery. It's about time. A 58-year-old sat across from me with knee pain. She’s otherwise healthy, but menopause has been rough on her. Her MRI shows some cartilage changes — age-appropriate,...
I loved my interview with legendary business analyst & founder of "Business Insider", Henry Blodget (@hblodget), on his podcast, "Solutions." Lots of smart questions about AI and healthcare, and how it'll change what it means to be a doctor and...
Best evidence yet that GLP-1 drugs reduce the risk of substance abuse, from >600,00 US Veterans across alcohol, nicotine, opioid, cocaine, cannabis @bmj_latest @zalaly @Miao_Cai_SLU https://t.co/rcqUt0kY77
Insulin has an inverse U-shape during aging, so by itself low values may be optimal, but also indicative of B-cell failure Adding HbA1c provides more context. If it's low with low insulin this is potentially good news Also check liver enzymes, to...
We've used a blood test—cell free DNA—for detecting cancer or prenatal fetal abnormalities. It turns out it can be used to detect liver diseases and all-cause mortality from other conditions @ScienceTM https://t.co/IJxPMq7hGU
When every state regulates consent differently, scale breaks. Mariann Yeager shares why model language and technical standards are critical for nationwide interoperability. 👇 https://t.co/Aa3zjJYTw4 @sequoiaproject #patientadvocates #HITSM https://t.co/I3cN0lmdLk
This is probably just the surface and it goes much deeper. The official journal of the Canadian Paediatric Society has just acknowledged that more than 100 of its case reports are fabricated. Incredible reporting from @RetractionWatch: https://retractionwatch.com/2026/03/03/canadian-pediatric-society-journal-correction-case-reports-fictional-paediatrics-child-health/
after just one year in the position, FDA COO Butler will retire, and his deputy will take over in April - https://t.co/9qmmIiuWX2
Blackstone puts $400M into Teva, Sanofi gut disease drug https://t.co/CkxPaI6CPr @ByJonGardner $TEVA $SNY $MRK $RHHBY
When your "normal" abdominal CT tells you about the 5-year future risks that can't be seen by radiologists, but can by AI (Merlin) https://t.co/DemC983uKz https://t.co/9jqZyVTD3p
$CTMX, +660% in 12 months, approaches its masked ADC catalyst. Via @ApexOnco -> https://t.co/oQI1iQiV4N ( $JANX -58% in the same timeframe)
It got me at "across all domains of life" Predicting pathogenicity of non-coding regions, produces sequences at genome scale, and much more Evo 2, open-source, @Nature today @arcinstitute @pdhsu @BrianHie https://t.co/9CZWmPFhjd
Last year, UnitedHealth Group disclosed 3,100 subsidiaries. This year? Just 10. The health care giant is paring back transparency right as its executives say they are embracing it. https://t.co/Wp1TYSUKTa
Batch effects once caused 162 patients to be misclassified. 28 of them received incorrect or unnecessary chemotherapy. The culprit? Contaminated RNA extraction that introduced technical artifacts into the data. https://t.co/WBBFKgvzVC
Healthcare AI ≠ just LLMs. CognomIQ unveils a semantic data operating system at ViVE 2026. One platform. End-to-end. From #ViVE2026 👇 https://t.co/HatKWPoOWo
Cancer blood tests for screening? Not the way they've been studied to date (age 50+) A new feature @Nature “I’m confident we’re going to see more accurate tests going forward. In high-risk groups, such as those with a genetic predisposition,...
I spent years teaching neurology residents that once cognitive decline begins, nothing can reverse it. A 20-year NIH trial just proved me wrong. The ACTIVE study — the largest cognitive training RCT ever conducted — found that just 10 hours of "speed...
Earlier diagnosis can change the trajectory of Alzheimer’s. Yet thousands of people in the UK still live with dementia for years before receiving a formal diagnosis. The signals are often already present in clinical records, they are simply fragmented across...
Maybe it's not new, but that's the first time I saw a digital tourniquet. It is designed to help anyone quickly stop the bleeding. No training required. Just tighten, press, and save a life. This is the line companies like XMetix...
New Device Detects Brain Waves in Mini Brains Mimicking Early Human Development by @ShellyFan https://t.co/oMMhx9ux8Q https://t.co/6321RBopxf
The gut and environmental toxins are key underpinnings of the Parkinson's disease pandemic @jclinicalinvest https://t.co/e8o4UuIafG https://t.co/7634Yg2Qo5
Tirzepatide: In the SURMOUNT-1 trial, weight reduction percentages were dose-dependent: 5 mg: ~15.0% weight reduction. 10 mg: ~19.5% weight reduction. 15 mg: ~20.9% weight reduction (Jastreboff et al., 2022). https://www.nejm.org/doi/10.1056/NEJMoa2206038 https://www.gatlan.com/ @GatlanHealth 
Prime Medicine $PRME to seek approval for gene editing treatment after two-patient trial https://t.co/nBnrUzqSCN via @Jasonmmast
Pierre Fabre seeks to revive US approval chances for spurned cell therapy https://t.co/gJeklT8asd @ByJonGardner $ATRA $QURE $RGNX
Did the FDA’s individualized therapy guidance put a spike in the heart of a startup biotech? Fake news, says the HHS. Yeah, it did, says an insider. Exclusive from @RLCscienceboss and @Jared_Whitlock https://t.co/IN9o4VIp03
Small language models (SLMs) are gaining attention in the generative AI field. SLMs are trained on relatively small amounts of data and have a relatively small number of parameters. SLM can be more practical than large language models as they are...
This week on Lifers, I interviewed @othman about how he navigated @color through three massive pivots—from cancer genetics to national COVID infrastructure and now a virtual cancer clinic. Timestamps: (00:00) Preview (00:58) Intro (01:03) Lessons from Figma and betting on the tortoise over the...
A new systematic review of LLMs in medicine @NatureMedicine @ekoermann https://t.co/npvDeqUvel “Despite thousands [4,609] of publications since late 2022, only a small fraction use real clinical data and just 19 randomized trials exist.”
T-cell engagers for autoimmunity. Listen to Ken Song describe the opportunity as CEO of San Diego-based Candid Therapeutics. Sponsored by @AlphaSenseInc & Dash Bio. https://t.co/Ct2viH00c4
What is the diagnostic yield of MRI in adult emergency patients with dizziness or vertigo? While MRI is efficient for detecting central causes of dizziness, its yield is low in cases of isolated dizziness without neurological signs. 👇 https://t.co/170qBbHrq7
New reporting from me taking you inside the $QURE - FDA Huntington's gene therapy imbroglio. I spoke to a senior FDA official late yesterday, who told me agency reviewers "are not convinced there’s any therapeutic benefit of the product. If...
Alzheimer’s research is increasingly looking beyond plaques and tangles to the brain’s immune response. A study published in Elsevier's Pharmacological Research journal used AI to screen 1.6M compounds for a Galectin-3 (Gal-3) blocker that could cross the brain barrier. In Alzheimer’s-like...
I remember what it was like to study the heart from textbooks and medical atlases. This video demonstrates how different the experience could be with mixed reality. It could lead to a new level of understanding of anatomy and pathology. The...
How to use ChatGPT as a doctor (properly) Not for diagnosis. Not to replace your brain. Use it to: • Simplify complex topics for patients • Draft patient education handouts • Create clinic SOPs • Generate content ideas • Structure research summaries • Prepare presentations • Improve communication clarity Think of...
@PBS: Five things to consider before asking a chatbot for health advice (by @AP_FDAwriter). Among them: ask two different AIs and see if they agree; don't stay home if you have red flag symptoms like chest pain, shortness of breath....
I’ll be joining a Zoom discussion hosted by Roon on March 5, 1:30-2:30 ET. We'll discuss how clinicians are using AI in actual practice and the implications. I'll be joined by 3 eminent colleagues: Mandy Cohen, Sara Murray, & Spencer...
In Colorado, we’ve been laser focused on saving Coloradans money on prescription drugs since day one, and it’s past time that Washington catches up. Colorado was the first state to cap insulin costs long before the federal government and expand...
The breakthrough blood test p-tau 217 for risk and diagnosis of Alzheimer's disease is more accurate than total p-tau 217, in a head-to-head comparison using PET imaging https://t.co/faILpVr9Ua https://t.co/lzUgFnFUP5
"There is no scientific evidence to support the assumption that banning minors from accessing services would have a positive effect on their mental health and development." https://t.co/eOCmTZvNiE
Onboarding your team or clinic to a new AI tool is so important, but often difficult. At Glass, we've made it incredibly easy — you can now get your whole clinic set up in a few minutes.
